CAS: 936694-12-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Glesatinib REF: TR-G407030CAS: 936694-12-1 | - - - | 5,338.00 € | Fri 10 Jan 25 |
 | Glesatinib REF: 3D-LMB69412CAS: 936694-12-1 | Min. 95% | To inquire | Mon 13 Jan 25 |
 | Glesatinib REF: TM-T15384CAS: 936694-12-1 | 98% | 1,000.00 €~2,617.00 € | Tue 21 Jan 25 |
Glesatinib
Controlled ProductCAS:936694-12-1
Formula:
C31H27F2N5O3S2
Color and Shape:
Neat
Molecular weight:
619.705
Ref: TR-G407030
| 100mg | 5,338.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
Glesatinib
CAS:936694-12-1
Glesatinib is a peptide that has been developed as a research tool to study the …
Formula:
C31H27F2N5O3S2
Purity:
Min. 95%
Molecular weight:
619.7 g/mol
Ref: 3D-LMB69412
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Glesatinib
CAS:936694-12-1
Glesatinib is an orally active and potent dual inhibitor of MET/SMO.
Formula:
C31H27F2N5O3S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
619.7
Ref: TM-T15384
| 25mg | 1,549.00 € | ||
| 50mg | 2,038.00 € | ||
| 100mg | 2,617.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
